If KBLB was simply selling beverages or chicken, I would agree with you.
Biotech is a little different, though. Whether it be the "Holy Grail," Spider Silk or any other biotech firm's product. Overall, producing and selling in this space in general warrants uber-protection measures. Reverse-engineering a secret recipe is more serious with a company in relative startup status vs. one that's established, as well. Plus, as any sustainable company will attest to, the more they can monopolize a market, the more sustainable they will be. Competition is good. But, monopolization is better. Way better!
Let Mr. Thompson work on building his moat. Put up his barriers to entry. He's matured a lot as CEO. The current stock price reflects that. IMO, the future stock price will reflect it even more.
And, imagine this...
One day we get a PR that isn't deliberately vague, but, rather, filled with information that you, I, and every other shareholder and reader of said PR don't/doesn't have to read between the lines. Instead, our CEO reveals something that's cut and dry, like, let's say, "Today KBLB has signed a contract with XYZ Co. to produce X-amount of Spider Silk valued at $$$-Million to be delivered by Such and such Date." With all the XYZ's and X's filled in, of course. To read exactly as it should.
Concrete details after years of deliberate obfuscation will launch the share price into the stratosphere. As hopeabides said in a post a few days ago (Post # 157597), and I firmly believe, "You will see soon enough it has been slow walked."
IMO, it's a strategy for the company and share price as whole. I trust the strategy.
